✦ LIBER ✦

Myelodysplastic syndrome evolving to a mixed myeloid-lymphoid leukaemia

✍ Scribed by Dr. J. F. San Miguel; M. Gonzalez; M. C. Del Ca≁tizo; A. López-Borrasca

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 147 KB
Volume: 4
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2900040209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myelodysplastic syndromes: Their history

Myelodysplastic syndromes: Their history, evolution and relation to acute myeloid leukaemia

✍ Layton, D. M. ;Mufti, G. J. 📂 Article 📅 1986 🏛 Springer-Verlag ⚖ 1023 KB

Pure red cell aplasia evolving through t

Pure red cell aplasia evolving through the hyperfibrotic myelodysplastic syndrome to the acute myeloid leukemia: some pathogenetic aspects

✍ N. Suvajdzic; D. Marisavljevic; V. Jovanovic; M. Pantic; D. Sefer; M. Colovic 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 144 KB

Farnesyl transferase inhibitor (lonafarn

Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study

✍ Christophe Ravoet; Philippe Mineur; Valérie Robin; Louisette Debusscher; André B 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 101 KB

Continuous sequential infusion of fludar

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome

✍ Felicetto Ferrara; Salvatore Palmieri; Tiziana Izzo; Clelia Criscuolo; Cira Ricc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

Acute myeloid leukaemia (AML) secondary to myelodysplastic syndrome (MDS) is characterized by poor prognosis, namely in older patients. The combination of fludarabine (F) with cytarabine (ARA-C) AE G-CSF was proven as effective in patients with poor risk AML. The efficacy and toxicity of a regimen i

Lack of antileukemic activity of rapamyc

Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome

✍ Fernando Callera; Carlos O. Lopes; Evandro S. Rosa; Carla C. Mulin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Secondary malignancies in a child with H

Secondary malignancies in a child with Hodgkin's disease: Peripheral T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia

✍ Polychronopoulou, Sophia; Panagiotou, John P.; Papadakis, Theodora; Mavrou, Aria 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

Hodgkin's disease (HD) has been linked to an increase risk of second malignant neoplasms (SMN), especially non-Hodgkin's lymphoma (NHL) and acute nonlymphoblastic leukaemia (ANLL). The mutagenic property of cytotoxic therapy as well as defective immunity have been implicated as playing a major role